Stocks and Investing Stocks and Investing
Mon, June 27, 2022
Fri, June 24, 2022

Marie Thibault Maintained (ABT) at Strong Buy with Decreased Target to $130 on, Jun 24th, 2022


Published on 2024-10-27 21:37:48 - WOPRAI, Marie Thibault
  Print publication without navigation


Marie Thibault of BTIG, Maintained "Abbott Laboratories" (ABT) at Strong Buy with Decreased Target from $140 to $130 on, Jun 24th, 2022.

Marie has made no other calls on ABT in the last 4 months.



There are 8 other peers that have a rating on ABT. Out of the 8 peers that are also analyzing ABT, 1 agrees with Marie's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Danielle Antalffy of "SVB Leerink" Maintained at Hold and Held Target at $140 on, Thursday, April 21st, 2022


These are the ratings of the 7 analyists that currently disagree with Marie


  • Cecilia Furlong of "Morgan Stanley" Maintained at Buy with Decreased Target to $145 on, Tuesday, June 7th, 2022
  • Travis Steed of "B of A Securities" Maintained at Strong Buy and Held Target at $140 on, Tuesday, May 31st, 2022
  • Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Decreased Target to $125 on, Tuesday, May 17th, 2022
  • Jayson Bedford of "Raymond James" Maintained at Buy with Decreased Target to $135 on, Thursday, April 21st, 2022
  • Shagun Singh of "RBC Capital" Maintained at Buy with Decreased Target to $143 on, Thursday, April 21st, 2022
  • Vijay Kumar of "Evercore ISI Group" Maintained at Buy and Held Target at $114 on, Sunday, April 10th, 2022
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Decreased Target to $150 on, Friday, April 8th, 2022
Contributing Sources